Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute dystonia from etoposide.

D P Ascher1, R A Delaney

  • 1Department of Pharmacy, Regional Medical Center, Clark Air Force Base, The Philippines.

Drug Intelligence & Clinical Pharmacy
|January 1, 1988
PubMed
Summary

Etoposide, a chemotherapy drug, can cause acute dystonia, a movement disorder, in children with acute lymphoblastic leukemia. This is the first reported case of this specific side effect in pediatric patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arteriovenous fistula formation after a closed proximal tibial fracture in a child.

The Journal of bone and joint surgery. British volume·2011
Same author

Orthopaedic admissions due to sports and recreation injuries.

Irish medical journal·2009
Same author

The limping child: an algorithm to outrule musculoskeletal sepsis.

Irish journal of medical science·2007
Same author

Infantile botulism: an atypical case of an uncommon disease.

Pediatrics·1999
Same author

Group B streptococcal disease in a child beyond early infancy with a deficiency of the second component of complement (C2).

The Pediatric infectious disease journal·1999
Same author

Spontaneous bleeding associated with the use of the protease inhibitor ritonavir in a hemophiliac patient with human immunodeficiency virus infection.

The Pediatric infectious disease journal·1998

Area of Science:

  • Pediatric Oncology
  • Neuropharmacology
  • Hematology

Background:

  • Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
  • Etoposide is a frequently used chemotherapeutic agent in ALL treatment protocols.
  • Movement disorders are known but rare side effects of certain chemotherapy agents.

Observation:

  • An 11-year-old boy undergoing treatment for ALL developed acute dystonia.
  • The dystonic reaction occurred following the administration of etoposide.
  • This adverse event presented as involuntary muscle contractions.

Findings:

  • This case represents the first documented instance of acute dystonia linked to etoposide in a pediatric patient with ALL.
  • The temporal association suggests etoposide as the likely causative agent for the observed dystonia.
  • The patient's neurological symptoms resolved after discontinuation of the offending agent.

Implications:

  • Highlights the potential for etoposide to induce acute dystonia in pediatric oncology.
  • Suggests the need for increased vigilance and awareness of this rare side effect among clinicians treating pediatric ALL.
  • May inform future treatment guidelines and patient monitoring protocols for chemotherapy-induced movement disorders.

Related Experiment Videos